Latest period
$2.52B
YoY change
+51.3%
5Y CAGR
+21.3%
Peak year (2011)
$10.42B
Latest annual
$4.55B
Cash on Hand history chart for CME Group (CME) from 2000 to 2025
Latest: $4.55B
Cash on Hand growth chart for CME Group (CME) from 2000 to 2025
Latest: +51.3%
Cash on Hand history table for CME Group (CME) from 2000 to 2025
| 2025 | $4.55B | +51.3% | +$1.54B | ||
| 2024 | $3.01B | -0.6% | −$18.10M | ||
| 2023 | $3.02B | +7.4% | +$207.60M | ||
| 2022 | $2.82B | -4.5% | −$133.80M | ||
| 2021 | $2.95B | +70.1% | +$1.22B | ||
| 2020 | $1.73B | +6.1% | +$99.50M | ||
| 2019 | $1.63B | +12.9% | +$187.20M | ||
| 2018 | $1.45B | -27.4% | −$546.30M | ||
| 2017 | $1.99B | +2.1% | +$41.80M | ||
| 2016 | $1.95B | +10.6% | +$186.80M | ||
| 2015 | $1.77B | +22.5% | +$324.30M | ||
| 2014 | $1.44B | -43.2% | −$1.10B | ||
| 2013 | $2.54B | +52.8% | +$876.80M | ||
| 2012 | $1.66B | -84.1% | −$8.76B | ||
| 2011 | $10.42B | +110.8% | +$5.48B | ||
| 2010 | $4.94B | -21.3% | −$1.34B | ||
| 2009 | $6.29B | +933.8% | +$5.68B | ||
| 2008 | $607.97M | -42.0% | −$440.65M | ||
| 2007 | $1.05B | -72.9% | −$2.82B | ||
| 2006 | $3.87B | +5.9% | +$214.78M | ||
| 2005 | $3.66B | +389.2% | +$2.91B | ||
| 2004 | $747.51M | -8.0% | −$64.65M | ||
| 2003 | $812.17M | -74.2% | −$2.34B | ||
| 2002 | $3.15B | +66.1% | +$1.25B | ||
| 2001 | $1.90B | +6093.0% | +$1.87B | ||
| 2000 | $30.66M | — | — |
- 2025$4.55B+51.3%
- 2024$3.01B-0.6%
- 2023$3.02B+7.4%
- 2022$2.82B-4.5%
- 2021$2.95B+70.1%
- 2020$1.73B+6.1%
- 2019$1.63B+12.9%
- 2018$1.45B-27.4%
- 2017$1.99B+2.1%
- 2016$1.95B+10.6%
- 2015$1.77B+22.5%
- 2014$1.44B-43.2%
- 2013$2.54B+52.8%
- 2012$1.66B-84.1%
- 2011$10.42B+110.8%
- 2010$4.94B-21.3%
- 2009$6.29B+933.8%
- 2008$607.97M-42.0%
- 2007$1.05B-72.9%
- 2006$3.87B+5.9%
- 2005$3.66B+389.2%
- 2004$747.51M-8.0%
- 2003$812.17M-74.2%
- 2002$3.15B+66.1%
- 2001$1.90B+6093.0%
- 2000$30.66M—
Cash on Hand values are taken from CME Group's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Cash on Hand at CME Group (CME)
According to CME Group's latest reported financial statements, the company's latest reported cash and short-term investments is $2.52B. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual cash and short-term investments for CME Group (CME) came in at $4.55B – surged 51.3% year-over-year.
Through 2020–2025 (5 years), CME Group cash and short-term investments delivered a +21.3% annualised rate; with mixed annual results across the window.
CME Group cash and short-term investments plunged from $10.42B in 2011 to $4.55B in 2025, a 56.4% drawdown.
2011 marks the peak cash and short-term investments at $10.42B, with the historical low of $30.66M recorded in 2000.
CME Group Cash on Hand by Year
CME Group Cash on Hand 2025: $4.55B
CME Group posted cash and short-term investments of $4.55B in 2025, surged 51.3% from 2024.
CME Group Cash on Hand 2024: $3.01B
In 2024, CME Group reported cash and short-term investments of $3.01B, edged down 0.6% below 2023.
CME Group Cash on Hand 2023: $3.02B
CME Group cash and short-term investments in 2023 was $3.02B, grew 7.4% from 2022.
CME Group Cash on Hand 2022: $2.82B
2022's cash and short-term investments for CME Group came in at $2.82B, edged down 4.5% below 2021.
CME Group Cash on Hand 2021: $2.95B
CME Group cash and short-term investments in 2021 was $2.95B.
See more financial history for CME Group (CME).
Sector peers by Cash on Hand
Financial Services peers of CME Group (CME), ranked by their latest cash and short-term investments
| $1.48T | |
| $963.73B | |
| $624.53B | |
| $539.97B | |
| $471.55B | |
| $373.31B | |
| $21.99B | |
| $10.90B |
- $1.48T
- $963.73B
- $624.53B
- $539.97B
- $471.55B
- $373.31B
- $21.99B
- $10.90B
Frequently asked questions
CME Group (CME) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation